We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ITRK:LSEIntertek Group plc Analysis

Data as of 2026-09-02 - not real-time

£5,845.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At £5,845.00, Intertek Group plc shows a bullish moving-average alignment, with shorter averages sitting above longer ones. With RSI at 60.2 the momentum picture is approaching overbought, alongside a bearish MACD signal. The recent range runs from support at £5,830.00 up to resistance at £5,860.00.
Valuation screens as overvalued: a P/E of 28.5 sits in line with the sector average of 28.6. Revenue is growing at 5.9% on a 9.1% profit margin. The 2.83% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 1.4%, a beta of 0.39 and a maximum drawdown of 30.2%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

London South East1monIntertek Group Regulatory NewsIf there are positions or rights to subscribe to disclose in more...London South East28dIntertek Group Regulatory NewsIf there are positions or rights to subscribe to disclose in more...London South East29dIntertek Group Regulatory NewsIf there are positions or rights to subscribe to disclose in more...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 4943.65
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 28.5 versus sector average of 28.6
  • Trading above the 200-day average of 4943.65

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 28.5 versus sector average of 28.6
  • Return on equity of 29.9%
  • Dividend yield of 2.83%

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin9.07%
P/E Ratio28.5
ROE29.94%
ROA10.33%
Debt/Equity172.66
P/B Ratio8.5
Op. Cash Flow£596.7M
Free Cash Flow£457.4M
Industry P/E28.6

Technical Analysis

TrendBullish
RSI60.2
Support£5,830.00
Resistance£5,860.00
MA 20£5,843.75
MA 50£5,828.20
MA 200£4,943.65
MACDBearish
VolumeDecreasing
Fear & Greed Index92.61

Valuation

Fair Value£39.11
Target Price£5,897.25
Upside/Downside0.89%
GradeOvervalued
TypeBlend
Dividend Yield2.83%

Risk Assessment

Beta0.39
Volatility1.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.